Download or read book Translational Pancreatic Cancer Research written by Christoph W. Michalski and published by Springer Nature. This book was released on 2020-07-31 with total page 252 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book incorporates a multi-disciplinary approach to present how research results can be translated into clinical trials. The first part begins with a chapter on variants of pancreatic cancer, precursor lesions and groups of people at risk to developing the disease. There is a particular focus on intraductal papillary mucinous neoplasia as a large-scale clinical challenge in pancreatology. The next two parts focus on diagnosis, biomarkers and stratification that emphasize how various approaches to biomarker development are important as both prognostic and predictive tools. The final part consists of personalized treatment approaches that include preclinical models of pancreatic cancer and stromal, epigenetic and metabolism targeting as promising approaches to be translated into early phase clinical trials. Chapters within this part also deal with approaches that are close to being implemented in clinical practice or are already being tested in (early) clinical trials, such as those that targeting the immune systems and strategies to overcome immunotherapy resistance; phase 1 clinical trials and translational approaches in surgical treatment. Written by experts in their fields, Translational Pancreatic Cancer Research provides an outlook towards future directions by integrating information both from basic and clinical research and though demonstrating pathways to better understanding pancreatic cancer and current approaches to translating these into clinical practice.
Download or read book Hard but Hopeful the Clinical and Translational Research Progress in Pancreatic Cancer written by Taiping Zhang and published by Frontiers Media SA. This book was released on 2022-11-04 with total page 152 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Pancreatic Cancer written by Gloria H. Su and published by Springer Science & Business Media. This book was released on 2008-02-01 with total page 350 pages. Available in PDF, EPUB and Kindle. Book excerpt: Pancreatic ductal adenocarcinoma is the fourth leading cause of cancer death in the United States. Annually approximately 30,000 Americans are diagnosed with the disease and most will die from it within five years. P- creatic ductal adenocarcinoma is unique because of its late onset in age, high mortality, small tumor samples infiltrated with normal cells, and a lack of both early detection and effective therapies. Some of these characteristics have made studying this disease a challenge. Pancreatic cancer develops as a result of the accumulation of genetic alterations in cancer-causing genes, such as the oncogenes and the tumor-s- pressor genes. In the last decade, major progress has been made in identifying important oncogenes and tumor-suppressor genes for the disease. In Panc- atic Cancer: Methods and Protocols, we review the classical techniques that have contributed to the advances in pancreatic research and introduce new strategies that we hope will add to future breakthroughs in the field of cancer biology. Pancreatic Cancer: Methods and Protocols provides a broad range of protocols for molecular, cellular, pathological, and statistical analyses of s- radic and familial pancreatic cancer. It covers topics from in vitro cell c- tures to in vivo mouse models, DNA to protein manipulation, and mutation analyses to treatment development. We believe that our book will prove an invaluable source of proven protocols for those who are interested in either basic or translational research in pancreatic cancer.
Download or read book Pancreatic Cancer written by Douglas B. Evans and published by Springer Science & Business Media. This book was released on 2006-04-18 with total page 413 pages. Available in PDF, EPUB and Kindle. Book excerpt: The MD Anderson Solid Tumor Oncology series presents cutting-edge surgical treatment and medical therapy for specific sites. This volume, Pancreatic Cancer, addresses epidemiology and molecular biology, inherited syndromes, staging, surgical techniques, multimodality therapy, and emerging therapies. The individual chapters focus on narrow, specific topics to produce a reference work of value to those interested in pancreatic cancer from a clinical and translational research perspective. A must-have for surgical oncologists and general surgeons.
Download or read book Immune Landscape of Pancreatic Cancer Development and Drug Resistance written by Batoul Farran and published by Elsevier. This book was released on 2024-06-07 with total page 284 pages. Available in PDF, EPUB and Kindle. Book excerpt: Immune landscape of pancreatic cancer development and drug resistance explores the advances in immune-based therapies aimed at harnessing the power of the immune system against pancreatic cancer and rewiring tumor microenvironments to eradicate pancreatic cells. With a strong focus on the development of therapeutic methods to improve the survival rates of pancreatic cancer, this book also shows the latest trends in immune targeted approaches for pancreatic cancer treatment. In 12 chapters Immune landscape of pancreatic cancer development and drug resistance discusses the current understanding of PC development and its various mutational and immune features and explore some of the new immune-based therapies aimed at targeting pancreatic cancer. It covers the urgent need for developing novel therapeutic modalities and aims at delineating future fields and avenues of research in pancreatic cancer treatment. The book provides the reader with an updated understanding of the immune landscape of PC and an all-encompassing overview of the latest trends in immune targeted approaches for PC treatment. This book is a valuable resource for health professionals, scientists and researchers, students, and all those who wish to broaden their knowledge of the advances in immunotherapy in pancreatic cancer. Summarizes the potential combination strategies and latest clinical trials in pancreatic cancer Provides an in-depth overview of our current understanding of pancreatic cancer development, including its mutational and immune features Explores some of the new immune-based therapies aimed at targeting PC Shows pancreatic cancer progression and basic elements in tumor microenvironments and their role in PC progression, also covering immunotherapy strategies
Download or read book Targeted Therapy in Translational Cancer Research written by Apostolia-Maria Tsimberidou and published by John Wiley & Sons. This book was released on 2015-10-08 with total page 398 pages. Available in PDF, EPUB and Kindle. Book excerpt: Targeted Therapy in Translational Cancer Research for the Translational Oncology series provides a comprehensive overview of recent developments in our understanding of tumor biology, elucidates the roles of targets and pathways involved in carcinogenesis, and describes current state-of-the-art anticancer therapy, as well as the most promising areas of translational research and targeted therapy. Introduces cutting-edge ‘bench to bedside and back’ breakthroughs which have transformed the diagnosis, prognosis, and treatment of cancer Covers basic principles of targeted therapy, including immunotherapy and the roles of cancer stem cells, the microenvironment, angiogenesis, epigenetics, microRNAs, and functional imaging in precision medicine Summarises major advances in therapeutic management of hematologic malignancies and solid tumors using conventional therapy, targeted therapy, immunotherapy, or novel treatment modalities
Download or read book Select Population Based and Translational Research for Improving Pancreatic Cancer Early Detection written by Shiro Urayama and published by . This book was released on 2014 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt: Select Population-Based and Translational Research for Improving Pancreatic Cancer Early Detection.
Download or read book Pancreatic Cancer written by H. Riess and published by Springer Science & Business Media. This book was released on 2007-11-17 with total page 188 pages. Available in PDF, EPUB and Kindle. Book excerpt: Although pancreatic cancer is one of the most serious forms of cancers, the lack of clinical symptoms often limits curative treatment options. This book gives insight into the current understanding of the management of pancreatic cancer and considers recent findings in cancer research. It provides answers to questions of how to know when cancer is respectable, how to proceed when the diagnosis comes too late for a curative approach, and how to assess different study results.
Download or read book Pancreatic Cancer Basic Mechanisms and Therapies written by and published by Elsevier. This book was released on 2023-05-31 with total page 392 pages. Available in PDF, EPUB and Kindle. Book excerpt: Pancreatic Cancer: Basic Mechanisms and Therapies, Volume 159 in the Advances in Cancer Research, presents the latest release in this ongoing, well-regarded serial with invaluable information on the exciting and fast-moving field of cancer research. Pancreatic cancer (PC) is the third leading cause of cancer-related deaths in the United States. Greater than 90% PCs are Pancreatic ductal adenocarcinomas (PDAC) which have a dismal estimated 5-year overall survival of only 11%. PDAC is predicted to become the second leading cause of mortality in the United States by 2030. In the clinic, the PDAC patients often present with incurable disease at the time of first diagnosis. This cancer is particularly lethal because of its propensity to spread quickly to distant organs including the lymphatic system. PDAC metastasis occurs shortly after tumor initiation and is caused by a complex interaction between autonomous tumor cells and cellular elements of the tumor microenvironment. Although PDAC remains a challenging disease to treat and a leading cause of cancer-related deaths, progress is being made in disease etiology and pathogenesis, and intensive research is focused on developing optimal treatment approaches for patients. Considering the continuous progress being made in understanding PDAC pathogenesis and designing new therapies, it was considered timely to develop an up-to-date thematic issue of Advances in Cancer Research (ACR) focused on PDAC. In this thematic issue, we have included ten review articles by experts that cover cancer disparities, PDAC pathobiology, the roles of the tumor microenvironment, tumor heterogeneity, PC stem cells, genetic and signaling events critical for PDAC pathogenesis, Immunotherapy and chemoresistance in PDAC, and different PDAC mouse models. This special issue highlights recent research progress in PDAC, which bridges the gap between basic and clinical research. The recent overview of Racial Disparities in Pancreatic Cancer Clinical Trials; Overview the evolution of in vivo models for PDAC Up-to-date discussion of diverse genetic and molecular signaling changes in PDAC; Role of tumor heterogeneity in therapy resistance in PDAC; Chemoresistance in PDAC and how to overcome this challenge; Current and emerging approaches and strategies for advancing targeted therapy and immunotherapy for PDAC New insights into the role of epithelial-to-mesenchymal transition, tumor microenvironment (TME) and interactions of TME with cancer stem cells in PDAC pathogenesis, progression and therapeutic resistance
Download or read book Trends in Pancreatic Cancer Research written by Maxwell A. Loft and published by Nova Publishers. This book was released on 2005 with total page 144 pages. Available in PDF, EPUB and Kindle. Book excerpt: Carcinoma of the pancreas has markedly increased in incidence over the past several decades, and now ranks as the fourth leading cause of cancer death. Cancer of the pancreas is abnormal cell growth in the tissue of the pancreas which is a small organ (about six inches long) located next to the small intestine, behind the stomach. The pancreas has two main jobs in the body: to produce juices that help digest (break down) food and to produce hormones, such as insulin and glucagon, that help control blood sugar levels. Both of these hormones help the body use and store the energy it gets from food. The majority of pancreatic cancers are adenocarcinomas. Adenocarcinomas are tumours that arise from the exocrine portion of the pancreas. The exocrine portion of the pancrease produces digestive fluids. A small number of pancreatic cancers begin in the endocrine pancreas. The endocrine portion produces hormones (such as insulin). Despite the high mortality rate associated with pancreatic cancer, its aetiology is poorly understood, it is rarely curable and has an overall survival rate of less than 4%. Research on changing the survival rates of this stubborn disease is highlighted in this new book.
Download or read book Translational Insights Into Pancreatic Ductal Adenocarcinoma written by Peter Bailey and published by Frontiers Media SA. This book was released on 2022-04-26 with total page 256 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Translational Nanomedicine written by Robert A. Meyers and published by Wiley-Blackwell. This book was released on 2020-03-16 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: The largest high-level encyclopedia on molecular medicine is now publishing a topical volume on Nanomedicine. The long awaited volume gives a comprehensive overview on nanomaterials in drug delivery, imaging and as therapeutics.
Download or read book Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy written by Ganji Purnachandra Nagaraju and published by Academic Press. This book was released on 2019-02-26 with total page 223 pages. Available in PDF, EPUB and Kindle. Book excerpt: Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy edited by Dr. Nagaraju, PhD., DSc. focuses on overriding the resistance from chemotherapeutic drugs with a broader range of treatment options. It particularly focuses on stroma, tumor microenvironment, stem cells, stellate cells, transcription factors, growth factors, and important signaling pathways. This volume discusses topics such as pancreatic cancer biology, current therapeutic options, EMT, chemotherapy resistance mechanisms, and genetic manipulations and natural products to enhance the sensitivity of pancreatic cancer to chemotherapy. Additionally, it discusses small targeted molecules and pancreatic cancer trials, and nanotechnology-based drug delivery. Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy is a valuable source for researchers and advanced students in cancer and oncology as well as clinicians and medical students who are interested in learning more about ways to break pancreatic cancer resistance to chemotherapy. Modulates the biologic properties of stroma in pancreatic cancer by targeting the several chemotherapy resistance mechanisms to impede their malignant property by introducing new strategies and drugs Provides information about on-going research as well as clinical data on pancreatic cancer and detailed descriptions about therapeutic options for easy understanding Utilizes full color figures to help the understanding of the content and tables for easy comparison of information as well as quick access to it
Download or read book Diagnostic and Predictive Factors in Pancreatic Cancer Clinical and Translational Studies written by Maximilian Kordes and published by . This book was released on 2022 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Theranostic Approach for Pancreatic Cancer written by Ganji Purnachandra Nagaraju and published by Academic Press. This book was released on 2019-08-19 with total page 410 pages. Available in PDF, EPUB and Kindle. Book excerpt: Theranostic Approach for Pancreatic Cancer modulates the biologic properties of stroma in pancreatic cancer by targeting the several chemotherapy resistance mechanisms to impede their malignant property through introducing new strategies and drugs for tackling the disease. It brings information about ongoing research as well as clinical data about pancreatic cancer and provides detailed descriptions about diagnostic and therapeutic options for easy understanding. The book discusses several topics related to pancreatic cancer, such as stem cells, drug resistance and pancreatic tumor microenvironment, the latest developments in chemotherapy for metastatic cancer and chemoprevention, and epigenome as a therapeutic strategy. Additionally, it encompasses a discussion on theranostic clinical applications for personalized treatment and management of pancreatic cancer. The book is a valuable resource for cancer researchers, oncologists, and several members of the biomedical field who need to understand more about the diagnosis and treatment of pancreatic cancer. Provides information on the roadblocks of chemotherapy in patients with newly diagnosed and metastatic pancreatic cancer“/li> Discusses treatment options available currently and prospective options for the future Focuses especially on stroma, tumor microenvironment, stem cells, stellate cells, transcription factors, growth factors, and important signaling pathways as already tested types of treatment
Download or read book Irreversible Electroporation written by Boris Rubinsky and published by Springer Science & Business Media. This book was released on 2009-11-25 with total page 320 pages. Available in PDF, EPUB and Kindle. Book excerpt: Non-thermal irreversible electroporation is a new minimally invasive surgical p- cedure with unique molecular selectivity attributes – in fact it may be considered the first clinical molecular surgery procedure. Non-thermal irreversible electro- ration is a molecular selective mode of cell ablation that employs brief electrical fields to produce nanoscale defects in the cell membrane, which can lead to cell death, without an effect on any of the other tissue molecules. The electrical fields can be produced through contact by insertion of electrode needles around the undesirable tissue and non-invasively by electromagnetic induction. This new - dition to the medical armamentarium requires the active involvement and is of interest to clinical physicians, medical researchers, mechanical engineers, che- cal engineers, electrical engineers, instrumentation designers, medical companies and many other fields and disciplines that were never exposed in their training to irreversible electroporation or to a similar concept. This edited book is designed to be a comprehensive introduction to the field of irreversible electroporation to those that were not exposed or trained in the field before and can also serve as a reference manual. Irreversible electroporation is broad and interdisciplinary. Therefore, we have made an attempt to cover every one of the various aspects of the field from an introductory basic level to state of the art.
Download or read book Pancreatic Cancer written by National Cancer Institute and published by CreateSpace. This book was released on 2012-06-23 with total page 80 pages. Available in PDF, EPUB and Kindle. Book excerpt: The National Cancer Institute's Pancreatic Cancer: A Summary of NCI's Portfolio and Highlight of Recent Research Progress provides a retrospective analysis of progress such as trends in numbers of NCI-funded pancreatic cancer research projects, publications, initiatives, and clinical trials. In 2000, the National Cancer Institute (NCI) convened the Pancreatic Cancer Progress Review Group (PRG) to review the pancreatic cancer research field and make recommendations concerning the most urgent needs and promising directions for future NCI investment. The PRG's report, Pancreatic Cancer: An Agenda for Action provided priority recommendations in six major areas: Health of the Field and Overarching Issues; Tumor Biology; Risk, Prevention, Screening, and Diagnosis; Therapy; Health Services Research: Scientific Toolkit. In 2007, a Clinical Trials Planning Meeting on Pancreas Cancer Treatment was convened to discuss the integration of basic and clinical knowledge in design of clinical trials in pancreatic adenocarcinoma. A Consensus Report of the meeting published in November 2009 provided recommendations in the following emphasis areas: New Targets for Drug Development; Utility of Preclinical Models; Future Clinical Trials; Establishment of Biorepositories; Development of Biomarkers. NCI's efforts in pancreatic cancer research have increased our understanding of the biological basis for pancreatic cancer, developed potential means to reduce morbidity and mortality associated with the disease, and expanded pancreatic cancer research capacity. The following or some research highlights in the five key priority areas identified by the PRG: Tumor Biology – Research on the tumor biology of pancreatic cancer has increased understanding of factors critical to key steps in the progression of pancreatic cancers; Risk, Prevention, Screening, and Diagnosis – Results of NCI-sponsored research related to the risk, prevention, screening, and diagnosis of pancreatic cancer have identified potential markers associated with pancreatic cancer risk as well as potential diagnostic markers; Therapy – NCI-sponsored research on therapy for pancreatic cancer has investigated optimal timing, delivery, and drug combinations that may improve the treatment of pancreatic cancer.~
